B · Normal
[Fosun Pharma: Plans to repurchase A-shares for RMB 250 million to RMB 500 million] On November 22, Fosun Pharma (600196.SH) announced that the company’s board of directors has reviewed and approved a plan to repurchase A-shares through centralized bidding transactions. The total repurchase funds will not be less than 250 million yuan and not exceed 500 million yuan. The upper limit of the repurchase price is 33 yuan/share. The repurchase period is within 12 months from the date of review and approval by the board of directors. The repurchased shares will be used for future issuance of convertible bonds, implementation of employee stock ownership plans or equity incentive plans.
Comments